Primary Site >> Liver Cancer
Gene >> CCR5
|
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: Expression and function of CXC and CC chemokines in human malignant liver tumors: a role for human monokine induced by gamma-interferon in lymphocyte recruitment to hepatocellular carcinoma. PMID: 10385645 |
Ref: Reduced expression of chemokine receptors on peripheral blood lymphocytes in patients with hepatocellular carcinoma. PMID: 15180734 |
Ref: Chemokine receptors support infiltration of lymphocyte subpopulations in human hepatocellular carcinoma. PMID: 15639651 |
Ref: Lack of association of some chemokine system polymorphisms with the risks of death and hepatocellular carcinoma occurrence in patients with alcoholic cirrhosis: a prospective study. PMID: 17413295 Ref: [Different expressions of chemokine receptors in human hepatocellular carcinoma cell lines with different metastatic potentials]. PMID: 17456312 Ref: The role of chemokines as inflammatory mediators in chronic hepatitis C virus infection. PMID: 17875002 Ref: Glycosaminoglycans and their synthetic mimetics inhibit RANTES-induced migration and invasion of human hepatoma cells. PMID: 18025279 |
Ref: Vgamma9Vdelta2 T cell-mediated recognition of human solid tumors. Potential for immunotherapy of hepatocellular and colorectal carcinomas. PMID: 17764010 Ref: Chemokine system polymorphisms, survival and hepatocellular carcinoma occurrence in patients with hepatitis C virus-related cirrhosis. PMID: 18205260 Ref: Tumor cell apoptosis induces tumor-specific immunity in a CC chemokine receptor 1- and 5-dependent manner in mice. PMID: 18644849 |
Ref: Levels of chemokine receptors expressed on peripheral blood T lymphocytes of Egyptian patients with hepatocellular carcinoma. PMID: 20726319 |
Ref: First report on a series of HIV patients undergoing rapamycin monotherapy after liver transplantation. PMID: 20048692 Ref: Antitumor effect after radiofrequency ablation of murine hepatoma is augmented by an active variant of CC Chemokine ligand 3/macrophage inflammatory protein-1alpha. PMID: 20663902 |
Ref: CCL5-28, CCL5-403, and CCR5 genetic polymorphisms and their synergic effect with alcohol and tobacco consumptions increase susceptibility to hepatocellular carcinoma. PMID: 22374185 |
Ref: Maraviroc, a CCR5 antagonist, prevents development of hepatocellular carcinoma in a mouse model. PMID: 23326556 Ref: Inflammation-induced hepatocellular carcinoma is dependent on CCR5 in mice. PMID: 23526353 |
Ref: Subsets of myeloid-derived suppressor cells in hepatocellular carcinoma express chemokines and chemokine receptors differentially. PMID: 25891236 Ref: High-dose cyclophosphamide induces specific tumor immunity with concomitant recruitment of LAMP1/CD107a-expressing CD4-positive T cells into tumor sites. PMID: 26116901 |
Ref: Silencing of WWP2 inhibits adhesion, invasion, and migration in liver cancer cells. PMID: 26662306 Ref: CCR1 antagonism attenuates T cell trafficking to omentum and liver in obesity-associated cancer. PMID: 27046081 Ref: Interfering with CCL5/CCR5 at the Tumor-Stroma Interface. PMID: 27070698 Ref: Tumoral Immune Cell Exploitation in Colorectal Cancer Metastases Can Be Targeted Effectively by Anti-CCR5 Therapy in Cancer Patients. PMID: 27070705 Ref: CCR5 Polymorphism as a Protective Factor for Hepatocellular Carcinoma in Hepatitis B Virus-Infected Iranian Patients PMID: 27892677 |
Ref: Functional role of CCL5/RANTES for HCC progression during chronic liver disease. PMID: 28011329 |
Ref: Immune activation underlies a sustained clinical response to Yttrium-90 radioembolisation in hepatocellular carcinoma. PMID: 29440463 Ref: Gemcabene downregulates inflammatory, lipid-altering and cell-signaling genes in the STAM model of NASH. PMID: 29847555 Ref: An update on the recent advances in antifibrotic therapy. PMID: 30261763 |